Supernus Pharmaceuticals | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Abbott USD 1.78B 252M 2025-03
ANI Pharmaceuticals USD -13762000 17.74M 2024-12
Aurora Cannabis CAD 32.07M 31.47M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Canopy Growth CAD -121580000 9.67M 2024-12
Corcept Therapeutics USD 161.49M 108.55M 2024-12
Eisai JPY 29.55B 13.99B 2024-12
Eli Lilly USD 3.46B 2.08B 2025-03
Indivior 59M 29M 2025-03
Novo Nordisk 34.38B 9.05B 2024-09
Pacira USD 25.53M 24.05M 2024-12
Perrigo USD 151.3M 11.9M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12
United Therapeutics USD 423.5M 27M 2025-03
Xeris Pharmaceuticals USD -5113000 13.95M 2024-12



Supernus Pharmaceuticals Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.